{
  "nav": {
    "science": "Science",
    "technology": "Technology",
    "families": "For Families",
    "cta": "Access Platform",
    "scientific": "Scientific",
    "family": "Family",
    "opensource": "Open Source",
    "demo": "Demo"
  },
  "hero": {
    "badge": "Cerebral Valley x Anthropic Hackathon 2026",
    "title1": "Detecting Alzheimer's",
    "title2": "Through Voice",
    "subtitle": "The world's first Cognitive Voice Fingerprint engine. MemoVoice identifies subtle linguistic drift years before clinical diagnosis \u2014 through natural conversation analysis powered by Claude AI.",
    "ctaPrimary": "Start Monitoring",
    "ctaSecondary": "Read the Science",
    "vizStatus": "Analyzing voice patterns...",
    "scroll": "Scroll to explore",
    "domainLexical": "Lexical",
    "domainSyntactic": "Syntactic",
    "domainCoherence": "Coherence",
    "domainFluency": "Fluency",
    "domainMemory": "Memory"
  },
  "stats": {
    "dementiaLabel": "People living with dementia worldwide",
    "dementiaSource": "WHO 2023",
    "markersLabel": "Linguistic markers precede clinical diagnosis",
    "markersSource": "Fraser 2016",
    "dimensionsLabel": "Cognitive dimensions analyzed per session",
    "dimensionsSource": "CVF Engine",
    "domainsLabel": "Linguistic domains continuously monitored",
    "domainsSource": "MemoVoice"
  },
  "problem": {
    "label": "The Challenge",
    "title": "The Silent",
    "titleHighlight": "Progression",
    "p1": "Alzheimer\u2019s disease begins its assault on the brain <strong>up to 20 years before the first clinical symptom</strong>. By the time a patient receives a diagnosis, significant and irreversible neurodegeneration has already occurred.",
    "p2": "Current diagnostic methods \u2014 cognitive tests, brain imaging, cerebrospinal fluid analysis \u2014 are expensive, invasive, and typically only deployed after noticeable symptoms emerge. <strong>The average diagnosis comes 2\u20133 years after symptom onset.</strong>",
    "p3": "But research has revealed a crucial window: <strong>linguistic patterns begin to change years before other symptoms appear</strong>. These subtle shifts in how we speak \u2014 word choices, sentence structures, coherence patterns \u2014 are invisible to the human ear but detectable by AI.",
    "detection": "MemoVoice detects here",
    "stage1Year": "Years -10 to -5",
    "stage1Title": "Subtle Linguistic Shifts",
    "stage1Desc": "Word-finding difficulties, reduced vocabulary diversity, simpler sentence structures begin to emerge in natural speech.",
    "stage2Year": "Years -5 to -2",
    "stage2Title": "Measurable Cognitive Drift",
    "stage2Desc": "Semantic coherence declines, speech fluency changes, memory-dependent recall weakens across multiple domains.",
    "stage3Year": "Years -2 to 0",
    "stage3Title": "Noticeable Symptoms",
    "stage3Desc": "Family and friends begin to notice changes. Traditional cognitive tests start to show decline. Neurodegeneration accelerates.",
    "stage4Year": "Year 0+",
    "stage4Title": "Clinical Diagnosis",
    "stage4Desc": "Formal diagnosis is made. Significant irreversible neurodegeneration already present. Treatment options are limited."
  },
  "breakthrough": {
    "label": "The Breakthrough",
    "title": "A World First in",
    "titleHighlight": "Cognitive Monitoring",
    "subtitle": "MemoVoice introduces the Cognitive Voice Fingerprint \u2014 a revolutionary approach to detecting Alzheimer\u2019s through the subtle patterns hidden in everyday speech.",
    "feature1Title": "Cognitive Voice Fingerprint",
    "feature1Desc": "A unique 25-dimension vector capturing the complete linguistic profile of each individual, creating a deeply personal cognitive baseline.",
    "feature2Title": "Individual Baseline Drift",
    "feature2Desc": "Rather than comparing against population norms, MemoVoice measures each person against their own established baseline \u2014 detecting personal cognitive changes with precision.",
    "feature3Title": "Non-Invasive Monitoring",
    "feature3Desc": "Through natural conversation \u2014 no blood draws, no brain scans, no clinical visits. Just regular phone or video calls analyzed in real-time by advanced AI.",
    "feature4Title": "Confounder-Adjusted",
    "feature4Desc": "Illness, poor sleep, medication changes, and emotional distress are automatically factored in \u2014 reducing false positives and increasing clinical reliability."
  },
  "howItWorks": {
    "label": "How It Works",
    "title": "From Conversation to",
    "titleHighlight": "Early Detection",
    "subtitle": "Four simple steps that could change everything for your family.",
    "step1Title": "Regular Conversations",
    "step1Desc": "Natural phone or video calls with your loved one. No special equipment, no clinical setting \u2014 just everyday conversation.",
    "step2Title": "AI Feature Extraction",
    "step2Desc": "Claude AI analyzes speech in real-time, extracting a 25-dimension cognitive feature vector across five linguistic domains.",
    "step3Title": "Baseline Comparison",
    "step3Desc": "Each session is compared against the individual\u2019s personal cognitive baseline, detecting drift that population-level tests would miss.",
    "step4Title": "Clinical Alerts",
    "step4Desc": "A four-tier graduated alert system notifies clinicians and families of any significant cognitive drift, with detailed weekly narrative reports."
  },
  "science": {
    "label": "Scientific Foundation",
    "title": "Built on",
    "titleHighlight": "Decades of Research",
    "subtitle": "MemoVoice\u2019s approach is grounded in peer-reviewed research from leading institutions in computational linguistics and neurodegenerative disease.",
    "paper1Highlight": "81.92% accuracy",
    "paper1Finding": "Achieved 81.92% classification accuracy using linguistic features extracted from speech transcripts of the DementiaBank Pitt corpus, establishing that computational linguistic analysis can reliably detect AD.",
    "paper2Highlight": "Tracks progression",
    "paper2Finding": "Demonstrated that connected speech analysis can track disease progression over time, with linguistic measures correlating directly with neuropathological severity at autopsy.",
    "paper3Highlight": "Pre-dementia detection",
    "paper3Finding": "Showed that automatic speech analysis can distinguish between healthy controls, MCI, and AD patients with high sensitivity and specificity \u2014 even at the pre-dementia stage.",
    "paper4Highlight": "Speech-only viable",
    "paper4Finding": "The ADReSS challenge established rigorous benchmarks for detecting Alzheimer\u2019s from speech, demonstrating the viability of speech-only cognitive assessment across multiple research teams.",
    "cascadeTitle": "AD Linguistic Cascade Model",
    "cascadeSubtitle": "Based on Fraser 2016 taxonomy \u2014 tracking progressive linguistic deterioration stages",
    "cascade1Name": "Pre-symptomatic",
    "cascade1Desc": "Fluency micro-changes",
    "cascade2Name": "Semantic Memory",
    "cascade2Desc": "Lexical + coherence decline",
    "cascade3Name": "Syntactic Simplification",
    "cascade3Desc": "Grammar complexity reduction",
    "cascade4Name": "Discourse Collapse",
    "cascade4Desc": "Global coherence breakdown"
  },
  "domains": {
    "label": "Five Domains",
    "title": "25 Dimensions Across",
    "titleHighlight": "5 Linguistic Domains",
    "subtitle": "Each conversation is analyzed across five scientifically validated linguistic domains, with five features extracted per domain.",
    "lexicalName": "Lexical Richness",
    "lexicalDesc": "Vocabulary diversity, word frequency distribution, and type-token ratios. Among the earliest markers to show decline in Alzheimer\u2019s progression.",
    "syntacticName": "Syntactic Complexity",
    "syntacticDesc": "Sentence structure, clause embedding depth, and grammatical sophistication. Simplification patterns indicate disease progression.",
    "coherenceName": "Semantic Coherence",
    "coherenceDesc": "Topic consistency, propositional density, and logical flow between utterances. Critical for tracking semantic memory decline.",
    "fluencyName": "Speech Fluency",
    "fluencyDesc": "Pause patterns, filler words, repetitions, and speech rate. Often the first domain to show pre-symptomatic changes detectable by AI.",
    "memoryName": "Memory Recall",
    "memoryDesc": "Narrative completeness, temporal ordering, and detail retention. Directly reflects episodic and working memory function.",
    "compositeTitle": "Composite Z-Score",
    "compositeDesc": "All 25 features combine into a single composite z-score measuring overall cognitive drift from the individual\u2019s established baseline."
  },
  "technology": {
    "label": "The Technology",
    "title": "Powered by",
    "titleHighlight": "Claude AI",
    "p1": "MemoVoice leverages <strong>Claude Opus 4.6</strong> by Anthropic \u2014 one of the most advanced language models ever built \u2014 for both real-time feature extraction and deep clinical analysis.",
    "p2": "Using Claude\u2019s <strong>extended thinking capability</strong>, the system performs thorough clinical reasoning for weekly reports, considering the full context of a patient\u2019s linguistic trajectory, confounding factors, and domain-specific patterns.",
    "p3": "The result is a level of linguistic analysis that approaches \u2014 and in some dimensions surpasses \u2014 what human clinical linguists can achieve, delivered continuously and at scale.",
    "specModel": "Analysis Model",
    "specThinking": "Thinking Budget",
    "specFeatures": "Features / Session",
    "specProcessing": "Processing",
    "specModelVal": "Claude Opus 4.6",
    "specThinkingVal": "10,000 tokens",
    "specFeaturesVal": "25 dimensions",
    "specProcessingVal": "Real-time",
    "pipelineTitle": "Processing Pipeline",
    "pipe1Label": "Voice Input",
    "pipe1Sub": "Natural conversation recording",
    "pipe2Label": "Claude Opus 4.6",
    "pipe2Sub": "Feature extraction + extended thinking",
    "pipe3Label": "CVF Engine",
    "pipe3Sub": "25-dimension vector computation",
    "pipe4Label": "Baseline Comparison",
    "pipe4Sub": "Individual drift detection",
    "pipe5Label": "Clinical Output",
    "pipe5Sub": "Alerts + weekly narratives"
  },
  "families": {
    "label": "For Families",
    "title": "For the People Who",
    "titleHighlight": "Care Most",
    "subtitle": "We built MemoVoice for families who want to protect their loved ones. Because the best time to act is before you notice something is wrong.",
    "benefit1Title": "Peace of Mind",
    "benefit1Desc": "Continuous monitoring means you\u2019ll know about cognitive changes as early as possible \u2014 not months or years after they begin.",
    "benefit2Title": "Simple Weekly Reports",
    "benefit2Desc": "Clear, jargon-free reports written for families. Understand your loved one\u2019s cognitive health without a medical degree.",
    "benefit3Title": "Natural & Dignified",
    "benefit3Desc": "No clinical tests, no uncomfortable procedures. Just regular conversations \u2014 preserving your loved one\u2019s dignity and comfort.",
    "benefit4Title": "More Time to Plan",
    "benefit4Desc": "Early detection gives families critical time for care planning, treatment exploration, legal preparations, and meaningful time together.",
    "quote": "\u201CIf we had known earlier, we would have had more time. More conversations. More moments. That\u2019s what early detection gives you \u2014 <strong>time</strong>.\u201D",
    "quoteAttribution": "\u2014 The motivation behind MemoVoice"
  },
  "modes": {
    "label": "Two Modes",
    "title": "Prevention &",
    "titleHighlight": "Treatment",
    "subtitle": "MemoVoice adapts to where your loved one is on their journey \u2014 whether you\u2019re watching for early signs or supporting someone already diagnosed.",
    "preventionTag": "Prevention Mode",
    "preventionTitle": "Families Share Memories, AI Leads the Conversation",
    "preventionDesc": "You provide the memories \u2014 childhood stories, favorite holidays, career milestones, family traditions. MemoVoice\u2019s AI weaves them into warm, natural phone conversations with your loved one.",
    "preventionHow": "How it works",
    "preventionStep1": "Families upload memories: stories, names, places, life events",
    "preventionStep2": "AI crafts personalized conversation topics from those memories",
    "preventionStep3": "Regular phone calls feel natural \u2014 your loved one enjoys reminiscing",
    "preventionStep4": "While talking, the CVF Engine silently analyzes 25 cognitive dimensions",
    "preventionStep5": "Families receive weekly cognitive drift reports",
    "preventionKey": "Your loved one never feels tested. They simply enjoy a conversation about their own life \u2014 while MemoVoice watches for the earliest signs of cognitive change.",
    "treatmentTag": "Treatment Mode",
    "treatmentTitle": "Memory Activation Therapy for Diagnosed Patients",
    "treatmentDesc": "For people already diagnosed with Alzheimer\u2019s or MCI, MemoVoice becomes a therapeutic tool. AI-guided phone calls use personal memories to actively stimulate cognitive pathways and slow decline.",
    "treatmentHow": "Therapeutic approach",
    "treatmentStep1": "Structured reminiscence sessions built around the patient\u2019s life story",
    "treatmentStep2": "AI progressively guides recall from strong memories to weaker ones",
    "treatmentStep3": "Repeated memory activation strengthens neural connections",
    "treatmentStep4": "Sessions adapt in real-time to the patient\u2019s cognitive state",
    "treatmentStep5": "Clinicians receive detailed session reports tracking response patterns",
    "treatmentKey": "Research shows that regular reminiscence therapy can improve mood, reduce agitation, and help maintain cognitive function. MemoVoice delivers this at scale \u2014 personalized to each patient\u2019s unique life history.",
    "scienceBasis": "Scientific Basis",
    "sciencePoint1": "<strong>Reminiscence therapy</strong> is recognized by the Cochrane Collaboration as beneficial for mood and cognition in dementia patients",
    "sciencePoint2": "<strong>Autobiographical memory stimulation</strong> activates the medial temporal lobe and prefrontal cortex \u2014 regions affected earliest by Alzheimer\u2019s",
    "sciencePoint3": "<strong>Regular cognitive engagement</strong> through meaningful conversation contributes to cognitive reserve and may delay functional decline"
  },
  "cta": {
    "title1": "Start Protecting Your",
    "title2": "Loved Ones Today",
    "subtitle": "MemoVoice is currently in clinical development. Join our early access program to be among the first to experience the future of cognitive monitoring.",
    "primary": "Request Early Access",
    "secondary": "Read the Research"
  },
  "footer": {
    "brandDesc": "Cognitive Voice Fingerprint Engine for early Alzheimer\u2019s detection through linguistic analysis.",
    "researchHeader": "Research",
    "linkScience": "Scientific Foundation",
    "linkTech": "Technology",
    "linkFamilies": "For Families",
    "projectHeader": "Project",
    "projectOrg": "Cerebral Valley x Anthropic",
    "projectEvent": "Hackathon February 2026",
    "projectVersion": "CVF Engine v0.1.0",
    "bottomLine": "MemoVoice CVF Engine v0.1.0 \u2014 Built at the Cerebral Valley x Anthropic Hackathon, February 2026",
    "disclaimer": "For research and demonstration purposes",
    "linkPrivacy": "Privacy & HIPAA",
    "linkLegal": "Legal"
  },
  "scientific": {
    "heroTitle": "The Science Behind",
    "heroHighlight": "MemoVoice",
    "heroSubtitle": "A deep dive into the Cognitive Voice Fingerprint engine, the 25-dimension analysis framework, and the clinical research that makes early Alzheimer's detection through voice possible.",
    "engineLabel": "CVF Engine",
    "engineTitle": "Cognitive Voice Fingerprint",
    "engineHighlight": "Engine Architecture",
    "engineDesc": "The CVF Engine is the core of MemoVoice — a real-time linguistic analysis system that converts natural speech into a 25-dimension cognitive feature vector. Each conversation is processed through a multi-stage pipeline that extracts, normalizes, and compares linguistic features against the individual's personal baseline.",
    "pipelineTitle": "Processing Pipeline",
    "pipe1Title": "Audio Ingestion",
    "pipe1Desc": "Voice input is captured via standard phone or video calls. The audio stream is segmented and prepared for transcription with noise filtering and speaker diarization.",
    "pipe2Title": "Transcription & Normalization",
    "pipe2Desc": "Speech-to-text conversion produces a clean transcript. Text is normalized for filler removal, false starts, and cross-talk elimination while preserving diagnostically relevant disfluencies.",
    "pipe3Title": "Claude AI Feature Extraction",
    "pipe3Desc": "Claude Opus 4.6 with extended thinking analyzes the transcript across all 25 cognitive dimensions. Each feature is scored on a standardized scale using clinically-grounded rubrics.",
    "pipe4Title": "Baseline Comparison & Drift Detection",
    "pipe4Desc": "Current session scores are compared against the individual's rolling baseline using z-score normalization. Statistically significant deviations trigger graduated alerts.",
    "pipe5Title": "Clinical Report Generation",
    "pipe5Desc": "Weekly narrative reports synthesize multi-session trends, highlight concerning patterns, factor in confounders, and provide actionable clinical recommendations.",
    "dimensionsLabel": "25 Dimensions",
    "dimensionsTitle": "The 25-Dimension",
    "dimensionsHighlight": "Cognitive Vector",
    "dimensionsDesc": "Each conversation produces a 25-element vector spanning five linguistic domains. These dimensions were selected based on peer-reviewed research identifying the most sensitive markers of cognitive decline.",
    "domainLexical": "Lexical Richness",
    "lexical1": "Type-Token Ratio (TTR)",
    "lexical1Desc": "Measures vocabulary diversity — the ratio of unique words to total words. Declining TTR is among the earliest detectable markers of Alzheimer's.",
    "lexical2": "Brunet's Index",
    "lexical2Desc": "A length-independent measure of lexical richness that remains stable across different text lengths, providing reliable cross-session comparisons.",
    "lexical3": "Honoré's Statistic",
    "lexical3Desc": "Captures the proportion of words used only once (hapax legomena). Higher values indicate richer vocabulary; decline signals word-finding difficulties.",
    "lexical4": "Word Frequency Profile",
    "lexical4Desc": "Tracks the distribution of common vs. rare words. Alzheimer's patients increasingly rely on high-frequency, generic terms as access to specific vocabulary degrades.",
    "lexical5": "Semantic Word Categories",
    "lexical5Desc": "Monitors usage patterns across semantic categories (animals, tools, foods). Category-specific decline can indicate targeted semantic memory degradation.",
    "domainSyntactic": "Syntactic Complexity",
    "syntactic1": "Mean Clause Length",
    "syntactic1Desc": "Average number of words per clause. Progressive shortening indicates simplification of grammatical structures.",
    "syntactic2": "Embedding Depth",
    "syntactic2Desc": "Measures nested clause complexity. Reduced embedding depth reflects declining ability to construct and maintain complex grammatical relationships.",
    "syntactic3": "Dependent Clause Ratio",
    "syntactic3Desc": "Proportion of dependent to independent clauses. Decreasing ratios suggest loss of syntactic sophistication.",
    "syntactic4": "Parse Tree Height",
    "syntactic4Desc": "The maximum depth of syntactic parse trees. Shallower trees correlate with syntactic simplification in neurodegenerative conditions.",
    "syntactic5": "Grammatical Error Rate",
    "syntactic5Desc": "Frequency of grammatical errors relative to utterance count. Increasing errors beyond personal baseline indicate declining syntactic competence.",
    "domainCoherence": "Semantic Coherence",
    "coherence1": "Local Coherence",
    "coherence1Desc": "Semantic similarity between adjacent utterances. Declining local coherence indicates difficulty maintaining topic continuity.",
    "coherence2": "Global Coherence",
    "coherence2Desc": "How well the overall narrative connects to the central topic. Global coherence breakdown is a hallmark of advancing Alzheimer's.",
    "coherence3": "Propositional Density",
    "coherence3Desc": "The number of ideas expressed per utterance. Reduced density reflects declining ability to pack meaning into speech.",
    "coherence4": "Topic Maintenance",
    "coherence4Desc": "Ability to stay on topic without tangential drift. Increasing topic shifts suggest executive function decline.",
    "coherence5": "Referential Clarity",
    "coherence5Desc": "Proper use of pronouns and references. Ambiguous referencing (e.g., excessive use of 'thing' or 'that') indicates semantic access difficulties.",
    "domainFluency": "Speech Fluency",
    "fluency1": "Pause Frequency",
    "fluency1Desc": "Number of pauses per minute of speech. Increasing pause frequency beyond personal baseline often precedes other symptoms.",
    "fluency2": "Filler Word Rate",
    "fluency2Desc": "Usage of 'um', 'uh', 'like', and other fillers. Changes in filler patterns reflect real-time word retrieval difficulties.",
    "fluency3": "Speech Rate",
    "fluency3Desc": "Words per minute, adjusted for pause time. Declining speech rate indicates increased cognitive processing demands.",
    "fluency4": "Repetition Index",
    "fluency4Desc": "Frequency of word and phrase repetitions. Increasing repetitions suggest working memory limitations.",
    "fluency5": "Self-Correction Rate",
    "fluency5Desc": "Frequency of mid-sentence corrections and restarts. Changes in self-correction patterns reveal meta-cognitive awareness shifts.",
    "domainMemory": "Memory Recall",
    "memory1": "Narrative Completeness",
    "memory1Desc": "Proportion of expected story elements recalled. Declining completeness indicates episodic memory degradation.",
    "memory2": "Temporal Ordering",
    "memory2Desc": "Ability to recount events in correct chronological order. Temporal confusion is an early marker of hippocampal dysfunction.",
    "memory3": "Detail Specificity",
    "memory3Desc": "Level of specific detail provided in narratives. Shift from specific to generic details signals memory access difficulties.",
    "memory4": "Cue Responsiveness",
    "memory4Desc": "Ability to provide additional detail when prompted. Declining responsiveness to cues indicates deeper memory retrieval failure.",
    "memory5": "Cross-Session Consistency",
    "memory5Desc": "Consistency of recalled details across sessions. Increasing inconsistencies reveal progressing memory consolidation problems.",
    "claudeLabel": "Claude Integration",
    "claudeTitle": "Extended Thinking for",
    "claudeHighlight": "Clinical Analysis",
    "claudeDesc": "MemoVoice leverages Claude Opus 4.6's extended thinking capability — allocating up to 10,000 tokens of internal reasoning before producing each analysis. This allows the model to consider the full complexity of linguistic patterns, personal history, and confounding factors before generating clinically relevant insights.",
    "claudeFeature1": "Multi-session trajectory analysis with trend detection",
    "claudeFeature2": "Confounder identification: illness, medication, mood, fatigue",
    "claudeFeature3": "Domain-specific pattern recognition across all 25 dimensions",
    "claudeFeature4": "Confidence-weighted scoring with uncertainty quantification",
    "claudeFeature5": "Natural language clinical narratives for weekly reports",
    "validationLabel": "Clinical Validation",
    "validationTitle": "Research",
    "validationHighlight": "Foundation",
    "validationDesc": "The CVF Engine's approach is grounded in decades of peer-reviewed research in computational linguistics and neurodegenerative disease detection.",
    "validationStudies": "Key Studies",
    "study1": "Fraser et al. (2016) — Achieved 81.92% accuracy detecting Alzheimer's from speech transcripts using computational linguistic features.",
    "study2": "Ahmed et al. (2013) — Demonstrated longitudinal connected speech analysis can track AD progression, correlating with neuropathological severity.",
    "study3": "König et al. (2015) — Showed automatic speech analysis distinguishes healthy controls from MCI and AD with high sensitivity at pre-dementia stages.",
    "study4": "Luz et al. (2020) — The ADReSS Challenge established rigorous benchmarks for Alzheimer's detection from speech across multiple research teams.",
    "study5": "de la Fuente Garcia et al. (2020) — Comprehensive review establishing linguistic markers as viable biomarkers for neurodegenerative conditions.",
    "backToHome": "Back to Home"
  },
  "familyPage": {
    "heroTitle": "Protecting the People",
    "heroHighlight": "You Love Most",
    "heroSubtitle": "MemoVoice gives families something priceless: the ability to detect cognitive changes in loved ones years before traditional methods — through simple, natural conversations.",
    "storyLabel": "Why It Matters",
    "storyTitle": "Every Family Has",
    "storyHighlight": "a Story",
    "storyP1": "It often starts with something small. A repeated question. A forgotten name. A pause where there never used to be one. And by the time the family notices, the disease has often been progressing silently for years.",
    "storyP2": "Alzheimer's affects more than the person diagnosed — it reshapes entire families. The uncertainty, the delayed diagnosis, the feeling of lost time. MemoVoice was built to give families back what matters most: <strong>time</strong>.",
    "storyP3": "With MemoVoice, you don't have to wait for something to feel wrong. Continuous monitoring means cognitive changes are detected at their earliest, most subtle stages — when intervention can make the biggest difference.",
    "dignityLabel": "Dignity First",
    "dignityTitle": "Natural Monitoring That",
    "dignityHighlight": "Preserves Dignity",
    "dignityDesc": "Your loved one never feels tested, examined, or reduced to a patient. MemoVoice works through warm, natural conversations about their own life — their memories, their stories, their experiences.",
    "dignity1Title": "No Clinical Setting Required",
    "dignity1Desc": "Monitoring happens through regular phone calls from the comfort of home. No appointments, no waiting rooms, no intimidating medical equipment.",
    "dignity2Title": "Conversations, Not Tests",
    "dignity2Desc": "AI-guided calls are designed to feel like catching up with an old friend. Topics are drawn from your loved one's own memories and life experiences.",
    "dignity3Title": "Complete Privacy",
    "dignity3Desc": "All conversations are processed with strict privacy protections. No data is sold, shared, or used for anything other than your loved one's cognitive monitoring.",
    "dignity4Title": "Family-Centered Reports",
    "dignity4Desc": "Weekly reports are written in clear, jargon-free language. You don't need a medical degree to understand your loved one's cognitive health.",
    "peaceMindLabel": "Peace of Mind",
    "peaceMindTitle": "From Worry to",
    "peaceMindHighlight": "Confidence",
    "peace1Title": "Know Early",
    "peace1Desc": "Detect subtle cognitive changes years before they become noticeable. Early awareness means more options and better outcomes.",
    "peace2Title": "Plan Ahead",
    "peace2Desc": "Early detection gives families critical time for care planning, financial preparation, legal arrangements, and treatment exploration.",
    "peace3Title": "Stay Connected",
    "peace3Desc": "Regular AI-guided conversations keep your loved one engaged and socially connected — proven to support cognitive health.",
    "peace4Title": "Act With Confidence",
    "peace4Desc": "Data-driven insights replace uncertainty. Know when it's time to talk to a doctor, backed by objective cognitive monitoring data.",
    "quoteText": "If we had known earlier, we would have had more time. More conversations. More moments where they were fully themselves. That's what early detection gives you — time.",
    "quoteAttribution": "The motivation behind MemoVoice",
    "ctaTitle": "Give Your Family the Gift of",
    "ctaHighlight": "Early Awareness",
    "ctaDesc": "Join our early access program and be among the first families to experience proactive cognitive monitoring.",
    "ctaButton": "Request Early Access",
    "backToHome": "Back to Home"
  },
  "opensource": {
    "heroTitle": "Open Source",
    "heroHighlight": "Cognitive Science",
    "heroSubtitle": "MemoVoice's core CVF Engine is fully open source under the MIT license. We believe that technology for detecting cognitive decline should be accessible to everyone.",
    "repoLabel": "Repository",
    "repoTitle": "MIT Licensed &",
    "repoHighlight": "Community Driven",
    "repoDesc": "The complete source code is available on GitHub. Fork it, modify it, deploy it locally, or build your own cognitive analysis tools on top of it.",
    "repoUrl": "github.com/memovoice/cvf-engine",
    "repoStars": "Star on GitHub",
    "repoFork": "Fork Repository",
    "repoDocs": "Documentation",
    "coreLabel": "Core Engine",
    "coreTitle": "What's",
    "coreHighlight": "Included",
    "core1Title": "CVF Engine Core",
    "core1Desc": "The complete 25-dimension cognitive feature extraction pipeline. Analyze speech transcripts and generate cognitive vectors using any compatible LLM.",
    "core2Title": "Baseline System",
    "core2Desc": "Individual baseline computation and drift detection algorithms. Statistical comparison engine with configurable sensitivity thresholds.",
    "core3Title": "Alert Framework",
    "core3Desc": "Four-tier graduated alert system from routine monitoring through urgent clinical notification. Fully customizable thresholds and routing.",
    "core4Title": "Report Generator",
    "core4Desc": "Weekly narrative report generation using AI. Produces clear, clinically relevant summaries of cognitive trends and patterns.",
    "customLabel": "Customization",
    "customTitle": "Build Your",
    "customHighlight": "Own Solution",
    "customDesc": "The open source engine is designed to be modular and extensible. Swap out components, add your own analysis dimensions, or integrate with your existing infrastructure.",
    "custom1Title": "Voice API Flexibility",
    "custom1Desc": "Switch between voice providers — Twilio, Vonage, or any SIP-compatible service. The engine is voice-API agnostic.",
    "custom2Title": "LLM Provider Switching",
    "custom2Desc": "While optimized for Claude, the engine supports any OpenAI-compatible API. Use GPT-4, Llama, Mistral, or your own fine-tuned models.",
    "custom3Title": "Local Deployment",
    "custom3Desc": "Run entirely on your own infrastructure. No external API calls required if you use a local LLM. Full data sovereignty guaranteed.",
    "custom4Title": "Custom Dimensions",
    "custom4Desc": "Add or modify cognitive dimensions beyond the default 25. Define custom scoring rubrics tailored to specific conditions or research needs.",
    "saasLabel": "SaaS Option",
    "saasTitle": "Prefer a Managed",
    "saasHighlight": "Solution?",
    "saasDesc": "Don't want to self-host? MemoVoice also offers a fully managed SaaS platform with all the features of the open source engine, plus dedicated infrastructure, automatic updates, and clinical support.",
    "saasFeature1": "Managed infrastructure with 99.9% uptime SLA",
    "saasFeature2": "Automatic updates and security patches",
    "saasFeature3": "HIPAA-compliant hosting and data handling",
    "saasFeature4": "Dedicated onboarding and clinical support team",
    "saasButton": "Contact for SaaS Pricing",
    "backToHome": "Back to Home"
  },
  "demo": {
    "heroTitle": "See MemoVoice",
    "heroHighlight": "In Action",
    "heroSubtitle": "Request a personalized demonstration and see how the Cognitive Voice Fingerprint engine detects subtle linguistic patterns in real-time.",
    "formLabel": "Request Demo",
    "formTitle": "Schedule Your",
    "formHighlight": "Demonstration",
    "formDesc": "Fill out the form below and our team will contact you within 24 hours to schedule a personalized demo.",
    "fieldName": "Full Name",
    "fieldNamePlaceholder": "Enter your full name",
    "fieldEmail": "Email Address",
    "fieldEmailPlaceholder": "you@organization.com",
    "fieldOrg": "Organization",
    "fieldOrgPlaceholder": "Hospital, research lab, or company name",
    "fieldRole": "Your Role",
    "fieldRolePlaceholder": "Select your role",
    "roleResearcher": "Researcher",
    "roleClinician": "Clinician",
    "roleCaregiver": "Family Caregiver",
    "roleDeveloper": "Developer",
    "roleOther": "Other",
    "fieldMessage": "What interests you most?",
    "fieldMessagePlaceholder": "Tell us about your use case...",
    "submitButton": "Request Demo",
    "submitNote": "We'll respond within 24 hours. No spam, ever.",
    "expectLabel": "What to Expect",
    "expectTitle": "Your Demo",
    "expectHighlight": "Experience",
    "expect1Title": "Live Analysis Demo",
    "expect1Desc": "Watch the CVF Engine process a real conversation transcript in real-time, extracting all 25 cognitive dimensions and generating a cognitive vector.",
    "expect2Title": "Dashboard Walkthrough",
    "expect2Desc": "Explore the monitoring dashboard — see how baseline comparisons work, how drift is detected, and how alerts are generated.",
    "expect3Title": "Report Examples",
    "expect3Desc": "Review sample weekly narrative reports showing how cognitive trends are communicated to families and clinicians in clear, actionable language.",
    "expect4Title": "Q&A Session",
    "expect4Desc": "Ask our team anything about the science, the technology, deployment options, or how MemoVoice can fit your specific needs.",
    "previewLabel": "Preview",
    "previewTitle": "Platform",
    "previewHighlight": "Highlights",
    "preview1": "Real-time 25-dimension cognitive analysis",
    "preview2": "Individual baseline tracking with drift detection",
    "preview3": "Four-tier graduated clinical alert system",
    "preview4": "AI-generated weekly narrative reports",
    "preview5": "Multi-language conversation support",
    "preview6": "HIPAA-compliant data handling",
    "backToHome": "Back to Home"
  },
  "privacy": {
    "heroTitle": "Privacy &",
    "heroHighlight": "HIPAA Compliance",
    "heroSubtitle": "MemoVoice is built with privacy as a core architectural principle. We believe cognitive health monitoring should never come at the cost of personal privacy.",
    "policyLabel": "Our Policy",
    "policyTitle": "Zero Data",
    "policyHighlight": "Collection",
    "policyDesc": "MemoVoice does not collect, store, or sell personal data. All cognitive analysis happens in real-time, and no conversation recordings or transcripts are retained beyond the immediate processing window.",
    "policy1Title": "No Conversation Storage",
    "policy1Desc": "Audio recordings and transcripts are processed in real-time and immediately discarded. Only computed cognitive feature vectors are retained for baseline comparison.",
    "policy2Title": "No Third-Party Sharing",
    "policy2Desc": "Your data is never shared with, sold to, or accessed by third parties. Period. No advertising, no data brokers, no exceptions.",
    "policy3Title": "No Behavioral Tracking",
    "policy3Desc": "We don't track user behavior, browsing patterns, or usage analytics beyond what's strictly necessary for the service to function.",
    "policy4Title": "User-Controlled Data",
    "policy4Desc": "All stored cognitive vectors can be exported or permanently deleted at any time by the account holder. Full data portability guaranteed.",
    "hipaaLabel": "HIPAA",
    "hipaaTitle": "HIPAA Safety",
    "hipaaHighlight": "Measures",
    "hipaaDesc": "MemoVoice is designed to meet HIPAA (Health Insurance Portability and Accountability Act) requirements for protected health information.",
    "hipaa1Title": "End-to-End Encryption",
    "hipaa1Desc": "All data in transit is protected with TLS 1.3 encryption. Stored cognitive vectors are encrypted at rest using AES-256.",
    "hipaa2Title": "Access Controls",
    "hipaa2Desc": "Role-based access control ensures only authorized users can view cognitive data. All access is logged and auditable.",
    "hipaa3Title": "Audit Logging",
    "hipaa3Desc": "Complete audit trail of all data access, modifications, and deletions. Logs are tamper-proof and retained per HIPAA requirements.",
    "hipaa4Title": "Business Associate Agreements",
    "hipaa4Desc": "BAAs are available for all healthcare partners. Cloud infrastructure providers are HIPAA-certified and covered under their own BAAs.",
    "encryptionLabel": "Encryption",
    "encryptionTitle": "Data",
    "encryptionHighlight": "Protection",
    "encryptionDesc": "Multiple layers of encryption protect data at every stage of processing.",
    "encrypt1": "TLS 1.3 for all data in transit",
    "encrypt2": "AES-256 encryption for data at rest",
    "encrypt3": "Encrypted database connections",
    "encrypt4": "Key rotation every 90 days",
    "encrypt5": "Hardware security modules (HSM) for key storage",
    "backToHome": "Back to Home"
  },
  "legal": {
    "heroTitle": "Legal &",
    "heroHighlight": "Licensing",
    "heroSubtitle": "MemoVoice is committed to transparency in how we build, license, and envision the future of accessible cognitive health technology.",
    "mitLabel": "License",
    "mitTitle": "MIT Open Source",
    "mitHighlight": "License",
    "mitDesc": "The MemoVoice CVF Engine is released under the MIT License — one of the most permissive open source licenses available. You are free to use, modify, distribute, and build upon this software for any purpose.",
    "mitPermit1": "Commercial use",
    "mitPermit2": "Modification",
    "mitPermit3": "Distribution",
    "mitPermit4": "Private use",
    "mitCondition": "The only condition is that the original MIT license and copyright notice must be included in any copy or substantial portion of the software.",
    "hackathonLabel": "Origin",
    "hackathonTitle": "Cerebral Valley x",
    "hackathonHighlight": "Anthropic Hackathon",
    "hackathonDesc": "MemoVoice was created at the Cerebral Valley x Anthropic Hackathon in February 2026. This event brought together developers, researchers, and AI enthusiasts to build meaningful applications using Anthropic's Claude AI.",
    "hackathonCredit1": "Built using Claude Opus 4.6 by Anthropic",
    "hackathonCredit2": "Developed during the February 2026 hackathon event",
    "hackathonCredit3": "Cerebral Valley community for the platform and inspiration",
    "hackathonCredit4": "All open source contributors and research community",
    "ngoLabel": "Future Vision",
    "ngoTitle": "Potential",
    "ngoHighlight": "NGO Future",
    "ngoDesc": "We envision MemoVoice evolving beyond a hackathon project into a nonprofit organization dedicated to making cognitive health monitoring accessible worldwide.",
    "ngo1Title": "Global Accessibility",
    "ngo1Desc": "Cognitive decline affects families everywhere. As an NGO, MemoVoice could provide free or subsidized monitoring to underserved communities worldwide.",
    "ngo2Title": "Research Partnerships",
    "ngo2Desc": "Nonprofit status enables deeper collaboration with academic institutions, hospitals, and research organizations without commercial conflicts of interest.",
    "ngo3Title": "Ethical AI Governance",
    "ngo3Desc": "An NGO structure ensures that decisions about cognitive health AI are guided by ethics and patient welfare — not shareholder returns.",
    "ngo4Title": "Community Ownership",
    "ngo4Desc": "The open source foundation means the technology belongs to everyone. An NGO would formalize this commitment to community ownership and transparent governance.",
    "disclaimerLabel": "Disclaimer",
    "disclaimerTitle": "Important",
    "disclaimerHighlight": "Notice",
    "disclaimerText": "MemoVoice is currently a research and demonstration project. It is not a medical device and is not intended to diagnose, treat, cure, or prevent any disease. The Cognitive Voice Fingerprint analysis is for research and informational purposes only. Always consult qualified healthcare professionals for medical advice and diagnosis.",
    "backToHome": "Back to Home"
  }
}
